Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy

E Jennifer Weil, Kevin V Lemley, Clinton C Mason, Berne Yee, Lois I Jones, Kristina Blouch, Tracy Lovato, Meghan Richardson, Bryan D Myers, Robert G Nelson, E Jennifer Weil, Kevin V Lemley, Clinton C Mason, Berne Yee, Lois I Jones, Kristina Blouch, Tracy Lovato, Meghan Richardson, Bryan D Myers, Robert G Nelson

Abstract

Podocyte detachment and reduced endothelial cell fenestration and relationships between these features and the classic structural changes of diabetic nephropathy have not been described in patients with type 2 diabetes. Here we studied these relationships in 37 Pima Indians with type 2 diabetes of whom 11 had normal albuminuria, 16 had microalbuminuria, and 10 had macroalbuminuria. Biopsies from 10 kidney donors (not American Indians) showed almost undetectable (0.03%) podocyte detachment and 43.5% endothelial cell fenestration. In patients with type 2 diabetes, by comparison, the mean percentage of podocyte detachment was significantly higher in macroalbuminuria (1.48%) than in normal albuminuria (0.41%) or microalbuminuria (0.37%). Podocyte detachment correlated significantly with podocyte number per glomerulus and albuminuria. The mean percentage of endothelial cell fenestration was significantly lower in macroalbuminuria (19.3%) than in normal albuminuria (27.4%) or microalbuminuria (27.2%) and correlated significantly with glomerular basement membrane thickness, albuminuria, fractional mesangial area, and the glomerular filtration rate (iothalamate clearance). Podocyte detachment and diminished endothelial cell fenestration were not correlated, but were related to classic lesions of diabetic nephropathy. Thus, our findings confirm the important role these injuries play in the development and progression of kidney disease in type 2 diabetes, just as they do in type 1 diabetes. Whether podocyte detachment creates conduits for proteins to escape the glomerular circulation and reduced endothelial fenestration lowers glomerular hydraulic permeability requires further study.

Trial registration: ClinicalTrials.gov NCT00340678.

Figures

Figure 1
Figure 1
Peripheral glomerular capillaries illustrating intact and detached podocyte foot processes from a macroalbuminuric Pima Indian with type 2 diabetes mellitus, trasnmission electron microscopy ×11,280. (a) Intact podocyte foot processes. (b) Podocyte foot process detachment. CL, capillary lumen; EC, endothelial cell; P, podocyte foot processes intact; PD, podocyte foot process detachment; RBC, red blood cell; WBC, white blood cell.
Figure 2
Figure 2
Peripheral glomerular capillaries illustrating an absence of normal endothelial cell fenestration, transmission electron microscoy ×11,280. (a) From a normal kidney donor, with normal endothelial cell fenestration. (b) Froma normoalbuminuric Pima Indian with type 2 diabetes mellitus and nonfenestrated endothelium. CL, capillary lumen; F, fenestrated endothelial cell; NF, nonfenestrated endothelial cell; RBC, red blood cell.
Figure 3
Figure 3
Correlations of albumin/creatinine ratio (ACR) or glomerular filtration rate (GFR) with percentage of podocyte detachment or percentage of normally fenestrated endothelium. (a, b) ACR (Pearson's r − 0.43, P = 0.0009) and GFR (Pearson's r = − 0.29, P = 0.084) as a function of percentage podocyte detachment in 37 Pima Indians with type 2 diabetes mellitus. The linear functions were not changed substantially by omission of the two individuals with the greatest amount of podocyte detachment. GBM, glomerular basement membrane. (c, d) ACR (Pearson's r = −0.51, P = 0.001) and GFR (Pearson's r = 0.45, P = 0.0005) as a function of the percentage of normally fenestrated endothelium in the same individuals. Regression lines and 95% confidence intervals are shown.

References

    1. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69:2131–2147.
    1. Satchell SC, Braet F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol. 2009;296:F947–F956.
    1. Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int. 2008;74:22–36.
    1. Steffes MW, Schmidt D, McCrery R, Basgen JM. International Diabetic Nephropathy Study Group. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int. 2001;59:2104–2113.
    1. White KE, Bilous RW Diabiopsies Study Group. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant. 2004;19:1437–1440.
    1. Susztak K, Raff AC, Schiffer M, Böttinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006;55:225–233.
    1. Miyauchi M, Toyoda M, Kobayashi K, et al. Hypertrophy and loss of podocytes in diabetic nephropathy. Intern Med. 2009;48:1615–1620.
    1. Lindenmeyer MT, Kretzler M, Boucherot A, et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol. 2007;18:1765–1776.
    1. Toyoda M, Najafian B, Kim Y, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes. 2007;56:2155–2160.
    1. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99:342–348.
    1. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia. 1999;42:1341–1344.
    1. Lemley KV, Abdullah I, Myers BD, et al. Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney Int. 2000;58:1228–1237.
    1. Dalla Vestra M, Masiero A, Roiter AM, et al. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003;52:1031–1035.
    1. Nakamura T, Ushiyama C, Suzuki S, et al. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant. 2000;15:1379–1383.
    1. Lemley KV, Blouch K, Abdullah I, et al. Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol. 2000;11:2095–2105.
    1. Drumond MC, Deen WM. Structural determinants of glomerular capillary hydraulic permeability. Am J Physiol (Fluid, Renal, Electrolyte) 1994;35:F1–F12.
    1. Singh A, Fridén V, Dasgupta I, et al. High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am J Physiol Renal Physiol. 2011;300:F40–F48.
    1. Nieuwdorp M, van Haeften TW, Gouverneur MC, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes. 2006;55:480–486.
    1. Lafayette RA, Druzin M, Sibley R, et al. Nature of glomerular dysfunction in pre-eclampsia. Kidney Int. 1998;54:1240–1249.
    1. Mauer SM, Steffes MW, Ellis EN, et al. Structural-functional relationships in diabetic nephropathy. J Clin Invest. 1984;74:1143–1155.
    1. Weil EJ, Lemley KV, Yee B, et al. Podocyte detachment in type 2 diabetic nephropathy. Am J Nephrol. 2011;33(suppl 1):21–24.
    1. Cohen AH, Mampaso F, Zamboni L. Glomerular podocyte degeneration in human renal disease: an ultrastructural study. Lab Invest. 1977;37:30–42.
    1. Eremina V, Sood M, Haigh J, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest. 2003;111:707–716.
    1. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358:1129–1136.
    1. Baelde HJ, Eikmans M, Lappin DW, et al. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int. 2007;71:637–645.
    1. Nelson RG, Meyer TW, Myers BD, Bennett PH. Course of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Kidney Int Suppl. 1997;63:S45–S48.
    1. Berhane AM, Weil EJ, Knowler WC, et al. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin J Am Soc Nephrol. 2011;6:2444–2451.
    1. Perkins BA, Ficociello LH, Silva KH, et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003;348:2285–2293.
    1. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, et al. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care. 2004;27:195–200.
    1. Schmidt K, Pesce C, Liu Q, et al. Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol. 1992;3:229–223.
    1. Nelson RG, Newman JM, Knowler WC, et al. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia. 1988;31:730–736.
    1. Tan JC, Busque S, Workeneh B, et al. Effects of aging on glomerular function and number in living kidney donors. Kidney Int. 2010;78:686–692.
    1. Hoy WE, Samuel T, Hughson MD, et al. How many glomerular profiles must be measured to obtain reliable estimates of mean glomerular areas in human renal biopsies? J Am Soc Nephrol. 2006;17:556–563.
    1. Jensen EB, Gundersen HJG, Osterby R. Determination of membrane thickness of distribution form orthogonal intercepts. J Microscopy. 1979;115:19–33.
    1. Weibel ER. Stereological Methods. New York: Academic Press; 1979. Volume 1: Practical Methods for Biological Morphometry.
    1. Guasch A, Sibley RK, Huie P, Myers BD. Extent and course of glomerular injury in human membranous glomerulopathy. Am J Physiol. 1992;264:F1034–F1043.
    1. Ting BD, Kristal B, Myers BD. The biophysical basis of hypofiltration in nephrotic humans with membranous nephropathy. Kidney Int. 1994;40:390–397.
    1. Vasquez B, Flock EV, Savage PJ, et al. Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycemia. Diabetologia. 1984;26:127–133.
    1. Chasson AL, Grady HJ, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol. 1960;30:207–212.
    1. Delanaye P, Radermecker RP, Rorive M, et al. Indexing glomerular filtration rate for body surface areas in obese patients is misleading: Concepts and example. Nephrol Dial Transplant. 2005;20:2024–2028.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する